H-Y antibody development associates with acute rejection in female patients with male kidney transplants

Transplantation

Volumn 86, Issue 1, 2008, Pages 75-81

  Tan, Jane C ^a   Wadia, Persis P ^a   Coram, Marc ^a   Grumet, F Carl ^b   Kambham, Neeraja ^b   Miller, Katherine ^a   Pereira, Shalini ^b   Vayntrub, Tamara ^b   Miklos, David B ^a,b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute rejection; Alloantibodies; H Y antigens; Kidney transplantation

Indexed keywords

HLA ANTIBODY; HY ANTIGEN; IMMUNOGLOBULIN G; ALLOANTIBODY; H Y ANTIBODY; H-Y ANTIBODY;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; CELL INFILTRATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT RECIPIENT; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PLASMA CELL; PRIORITY JOURNAL; WESTERN BLOTTING; ACUTE DISEASE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; BLOOD; DONOR; GRAFT REJECTION; IMMUNOLOGY; MIDDLE AGED; SEX DIFFERENCE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PLASMA CELLS; SEX FACTORS; TISSUE DONORS;

EID: 49849090195     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31817352b9     Document Type: Article

References (36)

1. Terasaki PI, McClelland JD. Microdroplet assay of human serum cyto-toxins. Nature 1964; 204: 998.
2. Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003; 3: 665.
3. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria - An addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708.
4. Ishii Y, Sawada T, Kubota K, et al. Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy. Kidney Int 2005; 67: 321.
5. Hourmant M, Cesbron-Gautier A, Terasaki PI, et al. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol 2005; 16: 2804.
6. Andresdottir MB, Haasnoot GW, Doxiadis II, et al. Exclusive characteristics of graft survival and risk factors in recipients with immunoglobulin A nephropathy: A retrospective analysis of registry data. Transplantation 2005; 80: 1012.
7. Crespo M, Sole M, Arostegui JL, et al. Diagnostic value of C4d in renal allograft biopsies in different clinical settings: Absence of C4d in grafts from non-heart-beating donors. Transplant Proc 2005; 37: 3688.
8. Hippen BE, DeMattos A, Cook WJ, et al. Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. Am J Transplant 2005; 5: 2248.
9. Herman J, Lerut E, van Damme-Lombaerts R, et al. Capillary deposition of complement C4d and C3d in pediatric renal allograft biopsies. Transplantation 2005; 79: 1435.
10. Koo DD, Roberts IS, Quiroga I, et al. C4d deposition in early renal allograft protocol biopsies. Transplantation 2004; 78: 398.
11. Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349: 125.
12. Opelz G. Success rate and impact of HLA matching on kidney graft survival in highly immunized recipients. Collaborative transplant study. Transpl Int 1992; 5(suppl 1): S601.
13. Zou Y, Stastny P, Susal C, et al. Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med 2007; 357: 1293.
14. Opelz G. Non-HLA Transplantation immunity revealed by lymphocy-totoxic antibodies. Lancet 2005; 365: 1570.
15. Zorn E, Miklos DB, Floyd BH, et al. Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. J Exp Med 2004; 199: 1133.
16. Eichwald EJ, Silmser CR. Skin graft success is limited by sex. Transplant Bull 1955; 2: 148.
17. Goulmy E, Termijtelen A, Bradley BA, et al. Alloimmunity to human H-Y. Lancet 1976; 2: 1206.
18. Miklos DB, Kim HT, Miller KH, et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood 2005; 105: 2973.
19. Greenfield A, Carrel L, Pennisi D, et al. The UTX gene escapes X inac-tivation in mice and humans. Hum Mol Genet 1998; 7: 737.
20. Lahn BT, Page DC. Functional coherence of the human Y chromosome. Science 1997; 278: 675.
21. Xu J, Burgoyne PS, Arnold AP. Sex differences in sex chromosome gene expression in mouse brain. Hum Mol Genet 2002; 11: 1409.
22. Miklos DB, Kim HT, Zorn E, et al. Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell Transplantation and in healthy female donors. Blood 2004; 103:353.
23. Troxell ML, Weintraub LA, Higgins JP, et al. Comparison of C4d im-munostaining methods in renal allograft biopsies. Clin J Am Soc Neph-rol 2006; 1: 583.
24. Sijpkens YW, Joosten SA, Wong MC, et al. Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy. Kidney Int 2004; 65: 2409.
25. Goulmy E, Termijtelen A, Bradley BA, et al. Y-antigen killing by T cells of women is restricted by HLA. Nature 1977; 266: 544.
26. Voogt PJ, Fibbe WE, Marijt WA, et al. Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet 1990; 335: 131.
27. Spierings E, Vermeulen CJ, Vogt MH, et al. Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation. Lancet 2003; 362: 610.
28. Randolph SS, Gooley TA, Warren EH, et al. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood 2004; 103:347.
29. Wang W, Meadows LR, den Haan JM, et al. Human H-Y: A male-specific histocompatibility antigen derived from the SMCY protein. Science 1995; 269: 1588.
30. Matas AJ, Gillingham KJ, Humar A, et al. Immunologic and nonim-munologic factors: Different risks for cadaver and living donor transplantation. Transplantation 2000; 69: 54.
31. Meehan SM, Domer P, Josephson M, et al. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol 2001; 32: 205.
32. Charney DA, Nadasdy T, Lo AW, et al. Plasma cell-rich acute renal allograft rejection. Transplantation 1999; 68: 791.
33. Desvaux D, Le Gouvello S, Pastural M, et al. Acute renal allograft rejections with major interstitial oedema and plasma cell-rich infiltrates: High gamma-interferon expression and poor clinical outcome. Nephrol Dial Transplant 2004; 19:933.
34. Herzenberg AM, Gill JS, Djurdjev O, et al. C4d deposition in acute rejection: An independent long-term prognostic factor. J Am SocNeph-rol 2002; 13: 234.
35. Mengel M, Bogers J, Bosmans JL, et al. Incidence of C4d stain in protocol biopsies from renal allografts: Results from a multicenter trial. Am J Transplant 2005; 5: 1050.
36. Tan JC, Wadia P, Grumet FC, et al. Antibodies against H-Y minor histocompatibility antigens are associated with acute rejection in female recipients of male kidney transplants [abstract]. FOCIS 2006, San Francisco, CA 2006.